These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21025284)

  • 1. Serial prothrombin estimations in cardiac patients; diagnostic and therapeutic implications; use of dicumarol.
    COTLOVE E; VORZIMER JJ
    Ann Intern Med; 1946 Apr; 24():648-65. PubMed ID: 21025284
    [No Abstract]   [Full Text] [Related]  

  • 2. Dilution curves and accuracy in prothrombin estimations during hepatitis and dicumarol therapy.
    MULLERTZ S
    Scand J Clin Lab Invest; 1953; 5(2):179-87. PubMed ID: 13089547
    [No Abstract]   [Full Text] [Related]  

  • 3. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of coagulation time in dicumarol therapy].
    DELLA SANTA R; FALLER R
    Schweiz Med Wochenschr; 1951 Dec; 81(50):1242-4. PubMed ID: 14913081
    [No Abstract]   [Full Text] [Related]  

  • 6. The action of dicumarol in the human being on plasma prothrombin time and total prothrombin time.
    QUICK AJ; HUSSEY CV; KASER M
    Am Heart J; 1952 Jul; 44(1):119-23. PubMed ID: 14933315
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimentally induced changes in the prothrombin level of the blood; quantitative studies in dogs given dicumarol; the effect of methylxanthines on prothrombin per se and when administered with dicumarol.
    QUICK AJ
    J Biol Chem; 1945; 161():33-44. PubMed ID: 21005712
    [No Abstract]   [Full Text] [Related]  

  • 8. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type].
    TRONNBERG G
    Nord Med; 1955 Jun; 53(26):1028-9. PubMed ID: 13244879
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of heparin on percentage content of prothrombin; range of variations and their significance in relation to heparin with dicumarol therapy].
    TAGLIACOZZO S
    Policlinico Chir; 1956; 63(3):141-59. PubMed ID: 13349502
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparin and dicumarol, anticoagulants; their prophylactic and therapeutic uses.
    AGGELER PM
    Cal West Med; 1946 Feb; 64():71-7. PubMed ID: 21016167
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimentally induced changes in the prothrombin level of the blood; prothrombin concentration of new-born pups of a mother given dicumarol before parturition.
    QUICK AJ
    J Biol Chem; 1946 Jul; 164():371-6. PubMed ID: 20989497
    [No Abstract]   [Full Text] [Related]  

  • 13. Experiences with dicumarol (3,3' methylene-bis-[4-hydroxycoumarin]) in the treatment of coronary thrombosis with myocardial infarction; preliminary report.
    WRIGHT IS
    Am Heart J; 1946 Jul; 32():20-31. PubMed ID: 20990916
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of depo-heparin on the prothrombin time, with observations on the combined use of heparin and dicumarol.
    HOLYOKE JB; WHEELWRIGHT HJ
    N Engl J Med; 1952 Jan; 246(1):15-7. PubMed ID: 14882481
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two methods for determining prothrombin during dicumarol therapy.
    BEGTRUP H
    Acta Med Scand; 1954; 150(1):11-6. PubMed ID: 13196956
    [No Abstract]   [Full Text] [Related]  

  • 16. Dicumarol therapy in acute coronary thombosis; results in fifty attacks; with review of data on embolic complications and immediate mortality in myocardial infarction.
    NICHOL ES; PAGE SW
    J Fla Med Assoc (1914); 1946 Jan; 32():365-70. PubMed ID: 21007277
    [No Abstract]   [Full Text] [Related]  

  • 17. The prothrombin level in patients on dicoumarol therapy; a simplified capillary technique.
    STEIN HB; WALLACE BV
    S Afr Med J; 1952 Apr; 26(17):353-5. PubMed ID: 14950380
    [No Abstract]   [Full Text] [Related]  

  • 18. Dicumarol; its use in acute coronary thrombosis.
    KOSSOVE AA
    South Med Surg; 1946 Oct; 108():309-12. PubMed ID: 21000502
    [No Abstract]   [Full Text] [Related]  

  • 19. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
    REHBEIN A; JARETZKI A; HABIF DV
    Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
    [No Abstract]   [Full Text] [Related]  

  • 20. Experiences with dicumarol in the treatment of coronary thrombosis.
    WRIGHT IS
    Proc Am Fed Clin Res; 1945; 2():101. PubMed ID: 20275642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.